These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30740878)

  • 1. Rectal Surgery Evaluation Trial: protocol for a parallel cohort trial of outcomes using surgical techniques for total mesorectal excision with low anterior resection in high-risk rectal cancer patients.
    Rouanet P; Gourgou S; Gogenur I; Jayne D; Ulrich A; Rautio T; Spinoglio G; Bouazza N; Moussion A; Gomez Ruiz M
    Colorectal Dis; 2019 May; 21(5):516-522. PubMed ID: 30740878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robotic, transanal, and laparoscopic total mesorectal excision for locally advanced mid/low rectal cancer: European multicentre, propensity score-matched study.
    de'Angelis N; Marchegiani F; Martínez-Pérez A; Biondi A; Pucciarelli S; Schena CA; Pellino G; Kraft M; van Lieshout AS; Morelli L; Valverde A; Lupinacci RM; Gómez-Abril SA; Persiani R; Tuynman JB; Espin-Basany E; Ris F;
    BJS Open; 2024 May; 8(3):. PubMed ID: 38805357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.
    Lelong B; de Chaisemartin C; Meillat H; Cournier S; Boher JM; Genre D; Karoui M; Tuech JJ; Delpero JR;
    BMC Cancer; 2017 Apr; 17(1):253. PubMed ID: 28399840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
    Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating a tumour appropriate transanal or robotic assisted approach to total mesorectal excision in high-volume rectal cancer practice is safe and cost-effective.
    Fleming C; Fernandez B; Boissieras L; Cauvin T; Denost Q
    J Robot Surg; 2023 Oct; 17(5):1979-1987. PubMed ID: 37099264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer: a retrospective propensity score-matched cohort study of short-term outcomes.
    Hol JC; Burghgraef TA; Rutgers MLW; Crolla RMPH; van Geloven NAW; Hompes R; Leijtens JWA; Polat F; Pronk A; Smits AB; Tuynman JB; Verdaasdonk EGG; Consten ECJ; Sietses C
    Br J Surg; 2021 Nov; 108(11):1380-1387. PubMed ID: 34370834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.
    Seow W; Dudi-Venkata NN; Bedrikovetski S; Kroon HM; Sammour T
    Tech Coloproctol; 2023 May; 27(5):345-360. PubMed ID: 36508067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transanal Total Mesorectal Excision in Mid-Low Rectal Cancer: Evaluation of the Learning Curve and Comparison of Short-term Results With Standard Laparoscopic Total Mesorectal Excision.
    Zeng Z; Liu Z; Huang L; Liu H; Jie H; Luo S; Zhang X; Kang L
    Dis Colon Rectum; 2021 Apr; 64(4):380-388. PubMed ID: 33394779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Minimally Invasive Resection Technique on Sphincter Preservation and Short-term Outcome in Low Rectal Cancer in the Netherlands.
    Rutgers ML; Detering R; Roodbeen SX; Crolla RM; Dekker JWT; Tuynman JB; Sietses C; Bemelman WA; Tanis PJ; Hompes R;
    Dis Colon Rectum; 2021 Dec; 64(12):1488-1500. PubMed ID: 33990499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transanal rectal resection: an initial experience of 20 cases.
    Buchs NC; Nicholson GA; Yeung T; Mortensen NJ; Cunningham C; Jones OM; Guy R; Hompes R
    Colorectal Dis; 2016 Jan; 18(1):45-50. PubMed ID: 26639062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-operative, oncological and functional outcomes of robotic versus transanal total mesorectal excision in patients with rectal cancer: A systematic review and meta-analysis.
    Mohamedahmed AYY; Zaman S; Wuheb AA; Ismail A; Nnaji M; Alyamani AA; Eltyeb HA; Yassin NA
    Tech Coloproctol; 2024 Jul; 28(1):75. PubMed ID: 38951249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Surgical Approaches and Outcomes in Total Mesorectal Excision and Margin Status for Rectal Cancer.
    Mirza MB; Gamboa AC; Irlmeier R; Hopkins B; Regenbogen SE; Hrebinko KA; Holder-Murray J; Wiseman JT; Ejaz A; Wise PE; Ye F; Idrees K; Hawkins AT; Balch GC; Khan A
    J Surg Res; 2024 Aug; 300():494-502. PubMed ID: 38875948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
    Marks JH; Myers EA; Zeger EL; Denittis AS; Gummadi M; Marks GJ
    Surg Endosc; 2017 Dec; 31(12):5248-5257. PubMed ID: 28643051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of early experience of robotic and transanal total mesorectal excision using propensity score matching.
    Law WL; Foo DCC
    Surg Endosc; 2019 Mar; 33(3):757-763. PubMed ID: 30014329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results.
    Sylla P; Sands D; Ricardo A; Bonaccorso A; Polydorides A; Berho M; Marks J; Maykel J; Alavi K; Zaghiyan K; Whiteford M; Mclemore E; Chadi S; Shawki SF; Steele S; Pigazzi A; Albert M; DeBeche-Adams T; Moshier E; Wexner SD
    Surg Endosc; 2023 Dec; 37(12):9483-9508. PubMed ID: 37700015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopy-Assisted Transanal Total Mesorectal Excision.
    Penchev DK; Ivanov PG; Mutafchiyski VM
    Folia Med (Plovdiv); 2019 Jun; 61(2):180-187. PubMed ID: 31301658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
    Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ
    Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.
    Zeng Z; Luo S; Chen J; Cai Y; Zhang X; Kang L
    Surg Endosc; 2020 Sep; 34(9):3956-3962. PubMed ID: 31586244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.